Meng-Chao Wu mainly focuses on Cancer research, Hepatocellular carcinoma, Internal medicine, Pathology and Carcinoma. His Cancer research research includes themes of Protein kinase B, microRNA, Immunology and In vivo. His Hepatocellular carcinoma research is multidisciplinary, incorporating perspectives in Survival rate, Surgery, Hepatectomy and Hepatitis B virus.
His Hepatectomy study combines topics in areas such as Retrospective cohort study and Hepatology. His Internal medicine research is multidisciplinary, incorporating elements of Gastroenterology, Endocrinology and Oncology. His Pathology research is multidisciplinary, relying on both Carcinogenesis, Cancer, Epithelial cell adhesion molecule and Metastasis.
Meng-Chao Wu spends much of his time researching Hepatocellular carcinoma, Internal medicine, Cancer research, Surgery and Gastroenterology. His Hepatocellular carcinoma research includes elements of Cirrhosis, Carcinoma, Pathology, Radiology and Hepatectomy. The Internal medicine study combines topics in areas such as Oncology and Hepatitis B virus.
His Cancer research study also includes
His primary scientific interests are in Hepatocellular carcinoma, Internal medicine, Gastroenterology, Carcinoma and Hepatectomy. His Hepatocellular carcinoma research is included under the broader classification of Cancer research. His work in Cancer research tackles topics such as Cell which are related to areas like Mesenchymal stem cell and Epithelial–mesenchymal transition.
His research investigates the connection with Internal medicine and areas like Oncology which intersect with concerns in Stage. His studies in Gastroenterology integrate themes in fields like Hazard ratio, Incidence, Risk factor, Survival analysis and Hepatitis B virus. His work in Carcinoma addresses subjects such as Surgery, which are connected to disciplines such as Transcatheter arterial chemoembolization.
His primary areas of study are Hepatocellular carcinoma, Internal medicine, Gastroenterology, Carcinoma and Proportional hazards model. His Hepatocellular carcinoma research entails a greater understanding of Cancer research. Meng-Chao Wu has included themes like Beta-catenin, Gene knockdown, CXCR4, Cancer cell and Molecular biology in his Cancer research study.
In his study, Incidence is strongly linked to Hepatectomy, which falls under the umbrella field of Internal medicine. His Gastroenterology study combines topics from a wide range of disciplines, such as Area under the curve, Propensity score matching, Hazard ratio, Resection and Hepatitis B virus. His research in Hazard ratio intersects with topics in Meta-analysis, Cochrane Library and Surgery.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Prognostic Nomogram for Intrahepatic Cholangiocarcinoma After Partial Hepatectomy
Yizhou Wang;Jun Li;Yong Xia;Renyan Gong.
Journal of Clinical Oncology (2013)
Wnt/β-Catenin Signaling Contributes to Activation of Normal and Tumorigenic Liver Progenitor Cells
Wen Yang;He-Xin Yan;Lei Chen;Qiong Liu.
Cancer Research (2008)
Tumor-derived exosomal miR-1247-3p induces cancer-associated fibroblast activation to foster lung metastasis of liver cancer.
Tian Fang;Hongwei Lv;Guishuai Lv;Ting Li.
Nature Communications (2018)
Sphere-forming cell subpopulations with cancer stem cell properties in human hepatoma cell lines
Lu Cao;Yanming Zhou;Beibei Zhai;Jian Liao.
BMC Gastroenterology (2011)
microRNA-22, downregulated in hepatocellular carcinoma and correlated with prognosis, suppresses cell proliferation and tumourigenicity
J Zhang;Y Yang;T Yang;Y Liu.
British Journal of Cancer (2010)
Surgical Treatment of Hepatocellular Carcinoma with Portal Vein Tumor Thrombus
Jie Shi;Eric C. H. Lai;Eric C. H. Lai;Nan Li;Wei-Xing Guo.
Annals of Surgical Oncology (2010)
Mutational landscape of intrahepatic cholangiocarcinoma
Shanshan Zou;Jiarui Li;Huabang Zhou;Christian Frech.
Nature Communications (2014)
Inhibition of Human Melanoma Growth and Metastasis in Vivo by Anti-CD44 Monoclonal Antibody
Yajun Guo;Jing Ma;Jinhong Wang;Xiaoyan Che.
Cancer Research (1994)
Endotoxin accumulation prevents carcinogen-induced apoptosis and promotes liver tumorigenesis in rodents.
Le-Xing Yu;He-Xin Yan;Qiong Liu;Wen Yang.
Hepatology (2010)
Effective tumor vaccine generated by fusion of hepatoma cells with activated B cells
Yajun Guo;Mengchao Wu;Hen Chen;Xiaoning Wang.
Science (1994)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:
Chinese University of Hong Kong
Second Military Medical University
The Ohio State University Wexner Medical Center
University of California, San Diego
Southern University of Science and Technology
Icahn School of Medicine at Mount Sinai
University of Hong Kong
Chinese Academy of Sciences
Shanghai Jiao Tong University
University of California, Los Angeles
Central South University
University of Pennsylvania
University of Alabama
Karlsruhe Institute of Technology
University of Pennsylvania
University of Science and Technology of China
INRAE : Institut national de recherche pour l'agriculture, l'alimentation et l'environnement
Washington University in St. Louis
University of Southampton
University of Granada
Scottish Enterprise
Carl von Ossietzky University of Oldenburg
Brighton and Sussex Medical School
National Foundation for Cancer Research
New York University